Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

801
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
801
Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

360
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
360
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

311
Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
311
Drug Distribution: Tissue Binding01:21

Drug Distribution: Tissue Binding

2.7K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
2.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

1.2K
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.2K
Drug Distribution: Volume of Distribution01:25

Drug Distribution: Volume of Distribution

5.3K
The volume of distribution refers to the theoretical volume necessary to contain the entire amount of an administered drug at the same concentration observed in the blood plasma. The body's intracellular fluid compartment, which makes up two-thirds of the total body water, is contrasted with the extracellular fluid compartment—comprising plasma and interstitial fluid—that accounts for one-third. The volume of distribution can vary depending on the characteristics of the drug.
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Public Health National Center for Innovations: An Initial Qualitative Evaluation.

Journal of public health management and practice : JPHMP·2022
Same author

Are We Ready to Build Back "Healthier?" An Exploratory Analysis of U.S. State-Level Disaster Recovery Plans.

International journal of environmental research and public health·2021
Same author

Exploring the Linkage Between Accreditation Outcomes and Public Health Emergency Preparedness and Response.

Journal of public health management and practice : JPHMP·2021
Same author

Impact of Accreditation on Health Department Financial Resources.

Journal of public health management and practice : JPHMP·2020

Related Experiment Video

Updated: Aug 3, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K

Opioid Litigation: Lessons Learned from a Retail Pharmacy Settlement.

Shannon A Gonick1

  • 1Boston University School of Law, Boston, MA, USA.

American Journal of Law & Medicine
|April 11, 2023
PubMed
Summary

State governments are suing retail pharmacies over their role in the opioid crisis. West Virginia settled its case with CVS in 2022, highlighting pharmacies

Area of Science:

  • Public Health
  • Legal Studies
  • Pharmaceutical Sciences

Background:

  • The United States faces a persistent opioid epidemic, prompting legal action against entities involved in opioid distribution.
  • State governments are increasingly filing lawsuits against retail pharmacies, alleging their contribution to the opioid crisis.
  • Retail pharmacies occupy a unique dual role as both distributors and dispensers of opioid medications.

Purpose of the Study:

  • To summarize the lawsuit filed by the State of West Virginia against CVS Pharmacy.
  • To examine the specific role of retail pharmacies in the opioid crisis, including distribution and dispensing.
  • To assess the legal viability of claims against retail pharmacies in ongoing opioid litigation.

Main Methods:

  • Review of the legal action initiated by West Virginia against CVS.
Keywords:
CVSOpioidsWest Virginialitigationretail pharmaciessettlement

More Related Videos

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K

Related Experiment Videos

Last Updated: Aug 3, 2025

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

10.7K
Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs
10:13

Author Spotlight: An Efficient Methodology to Confidently Differentiate and Characterize Fentanyl Analogs

Published on: November 8, 2024

2.3K
Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.7K
  • Analysis of the dual role of retail pharmacies in the opioid supply chain.
  • Assessment of legal precedents and potential causes of action in opioid litigation.

    • Main Results:

    • The State of West Virginia and CVS Pharmacy reached a settlement in the fall of 2022.
    • Retail pharmacies' position as both distributors and dispensers is central to their alleged contribution to opioid oversaturation and diversion.
    • The article provides an assessment of the legal strategies and potential outcomes for similar cases.

    Conclusions:

    • The West Virginia v. CVS settlement offers insights into resolving state-led opioid litigation against retail pharmacies.
    • Understanding the complex role of pharmacies is crucial for addressing the opioid epidemic through legal and public health interventions.
    • Further legal actions will likely continue to explore various causes of action against retail pharmacies.